![](/img/cover-not-exists.png)
Dalbavancin safety in the phase 2/3 clinical development program
E Seltzer,L Goldberg,D Krause,D Simoneau,E BoudryVolume:
12
Language:
english
Journal:
Critical Care
DOI:
10.1186/cc6248
Date:
March, 2008
File:
PDF, 12.16 MB
english, 2008